Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial
2013 ◽
Vol 15
(5)
◽
pp. 432-440
◽
2017 ◽
Vol 19
(6)
◽
pp. 874-882
◽
2017 ◽
Vol 18
(13)
◽
pp. 1291-1300
◽
2018 ◽
Vol 33
(suppl_1)
◽
pp. i317-i318
2012 ◽
Vol 34
(9)
◽
pp. 1909-1919.e15
◽
Keyword(s):